From 22nd to the 25th August we presented papers simultaneously in Stockholm, Sweden, Milan, Italy and Puerto Rico in the Caribbean.
This happens once in a lifetime of research; for a scientist, its like being on the front page of Times Magazine. The paper is called: GC protein-derived macrophage-activating factor decreases a-N-acetylgalactosaminidase levels in advanced cancer patients. Or to translate: GcMAF decreases nagalase in advanced cancer patients. It follows the excellent improvements in 20 cancer patientsRead More
Professor Marco Ruggiero MD joins us on the 1st November as Consultant Scientific Director
Dr Bradstreet has 85% responders, 15% full recoveries, another paper on autism. Read the paper here: http://www.la-press.com/initial-observations-of-elevated-alpha-n-acetylgalactosaminidase-activ-article-a3450-abstract